tirzepatide is fda approved approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide vs. Semaglutide: What You

The proportion of people with fibrosis improvement was statistically similar in all groups: 46%, 32%, 43% and 31%, respectively

[DOI] [PubMed] [Google Scholar] 28.Traverso G, Schoellhammer CM, Schroeder A, et al

doi:10.1016/j.tig.2022.01.005

Clinical trials conducted during the drug's development and post-marketing surveillance have not identified a significant association between semaglutide use and increased ulcer incidence

Potential Benefits Supported by Research While research on tirzepatide specifically for endometriosis is limited, studies on related GLP-1 receptor agonists provide insights: Inflammation reduction: GLP-1 receptor agonists have shown anti-inflammatory effects in various tissues, which may help reduce endometrial lesion inflammation